CClinicalTrials.gg
RecruitingNCT05231343COMPACTUpdated May 24, 2023

Comparing Dual Mini-fragment Plating to Single Precontoured Plating of Acute Midshaft Clavicle Fractures Trial

An interventional study of Dual Mini-fragment Plating and Single Precontoured Plating in Clavicle Fracture, sponsored by Sunnybrook Health Sciences Centre. Recruiting at 1 site in Canada. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-05-24.

Sponsored by Sunnybrook Health Sciences Centre · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Apr 2022; still recruiting 4 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The rate of surgical fixation of fractures of the collarbone (i.e., midshaft clavicle) has exponentially increased in recent years; however, the rate of repeat procedures for removal of these implants (i.e., plates) due to irritation remains high. Despite technological advances in implant design, nearly one in four patients with a surgically fixed collarbone ultimately undergoes removal of their implant. More recently, there has been a growing body of literature demonstrating the effectiveness of using two smaller caliber plates, which have been found to have similar rates of implant removal. As such, the proposed randomized clinical trial seeks to be the first level I study to directly compare dual mini-fragment plating of acute displaced midshaft clavicle fractures to single precontoured plating. The investigators hypothesize that dual mini-fragment plating will result in lower rates of reoperation with similar rates of union and complication.

Read the detailed description

Midshaft clavicle fractures have traditionally been treated non-operatively with immobilization in a sling or a figure-of-eight bandage. Early studies reported a non-union rate of 1% and negligible functional consequence with conservative management. However, the inclusion of pediatric fractures and an absence of modern functional assessments in these studies resulted in an underestimation of non-union rates and overly optimistic clinical outcomes. More recent data has demonstrated a non-union rate of 15% with approximately 30% of patients dissatisfied with their outcome following non-operative treatment. As a result, there has been renewed interest in surgical fixation of displaced midshaft clavicle fractures. In fact, the rate of operative fixation has exponentially increased following the publication of a landmark randomized controlled trial by the Canadian Orthopaedic Trauma Society (COTS) which was the first of many level I studies to demonstrate higher union rates, decreased rates of symptomatic malunion, earlier return to function, and improved patient-reported outcomes with plate fixation of displaced midshaft clavicle fractures.

Traditional plating techniques for open reduction and internal fixation of clavicle fractures involved the use of a single 3.5-mm plates placed superiorly or anteriorly. However, these plates are often very prominent under the skin causing irritation, and in many cases result in reoperation for hardware removal. The rate of reoperation for removal of symptomatic hardware has been reported to range from 8% to 66%. For this reason, there have been a number of different fixation strategies describes to minimize the need to return to the operating room for implant-related symptoms. These include intramedullary nailing and the use of anatomic precontoured clavicle plates positioned superiorly or anteroinferiorly. However, even with the use of precontoured plates, the reported hardware removal rate varies from 5% to 47%. This is likely due to the significant variation in clavicle anatomy (i.e., sigmoid curve, coronal bow and length) observed between individuals which precludes anatomic fitting of precontoured plates in all patients. In fact, Malhas and colleagues published a cadaveric study that found further contouring of precontoured plates was necessary in 73% of cases to optimize plate-bone fit.

More recently, a dual plate construct using two mini-fragment plates (i.e., 2.4-mm or 2.7-mm plates) placed orthogonally has been advocated as a means of decreasing the rate of reoperation for symptomatic hardware removal. In 2015, Prasarn et al. reported on a series of 17 patients undergoing clavicle fixation using a 2.7-mm plate positioned superiorly and a 2.4-mm plate positioned anteriorly and had no reoperations while noting a 100% union rate. The idea of dual plating is not new and is commonly used in the setting of clavicle fracture non-union fixation. Its efficacy has also been described in distal clavicle fractures. Dual plating may serve as the ideal low-profile implant option to help diminish the high rates of symptomatic implant removal observed with single plating. The benefits associated with a dual plate construct extend beyond a reduction in implant-related soft-tissue irritation. Intraoperatively, dual plating allows for more points of fixation, buttressing of anterior butterfly fragments, mini-fragment plates to be used as washers for multiple lag screws, and the use of either the superior or anterior plate as a reduction aid or clamp, while the second plate is applied. Based on existing biomechanical data in the literature, the ability of a dual plate construct to withstand multiplanar bending forces better than a single plate construct may also allow for early weight-bearing through the affected extremity. Despite the aforementioned benefits of dual plate fixation, there remains a lack of level I evidence for its use in the surgical management of acute midshaft clavicle fractures.

02

Conditions studied

  • Clavicle Fracture

Browse trials for

Keywords

  • Orthogonal plating
  • Hardware removal
  • Reoperation
03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

This study's planned enrollment of 66 is close to the median of 69 across 1,482 interventional studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

Sunnybrook Health Sciences Centre is the lead sponsor of 566 studies on the registry; 134 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 2 (33%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Between 18 and 65 years of age
  • A completely displaced midshaft fracture of the clavicle (no cortical contact between the main proximal and distal fragments (AO/OTA 15.2A/B/C)
  • Fracture amenable to plate fixation with a minimum of three screws in each proximal and distal fragment

Exclusion criteria

Exclusion Criteria:

  • Open fracture
  • Pathological fracture
  • Fracture seen > 28 days after injury
  • Associated neurovascular injury
  • Associated head injury (Glasgow Coma Scale \< 12)
  • Concomitant ipsilateral upper extremity fracture
  • Significant medical comorbidities (i.e., ASA grade IV and V)
  • Inability to comply with follow-up and
  • Lack of consent
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
66 participants (estimated)

Study arms

  • Experimental
    Dual mini-fragment plating

    Procedure: Dual Mini-fragment Plating

  • Active comparator
    Single precontoured plating

    Procedure: Single Precontoured Plating

Interventions

  • ProcedureDual Mini-fragment Plating

    Patients randomized to dual mini-fragment plating will undergo clavicle fixation using any configuration of 2.0-mm, 2.4-mm and 2.7-mm limited contact dynamic compression (LC-DCP), locking compression (LCP) or reconstruction plates (i.e., 2.4-mm superior and 2.7-mm anteroinferior). One of the two plates used must be a LC-DCP or LCP plate. Surgeons will contour the mini-fragment plate intraoperatively to fit each patient's anatomy.

  • ProcedureSingle Precontoured Plating

    Patients randomized to a single plate construct will undergo fixation using an anatomically precontoured (superior or anterior-inferior) clavicle plate.

06

What researchers measure

Primary outcomes

  1. Removal of hardware at two years of follow-up

    The proportion of people that had their clavicle hardware removed by the two year follow-up.

    Time frame: 24 months postop

Secondary outcomes

  1. Radiographic union

    Complete cortical bridging between the proximal and distal fragments on both views.

    Time frame: 6 weeks, 3 months, 6 months, 12 months and 24 months postop

  2. Reoperation causes other than hardware removal

    The proportion of people undergoing reoperation for reasons other than hardware removal.

    Time frame: 6 weeks, 3 months, 6 months, 12 months and 24 months postop

  3. Adverse events/complications

    Any event that necessitates another operative procedure or additional medical treatment. Nonunion will be defined as a lack of radiographic healing with clinical evidence of pain and motion at the fracture site at one year. Complex regional pain syndrome will be diagnosed by the presence of dysesthesia and hyperesthesia extending into the hand of the operative limb, with associated vasomotor changes, skin atrophy and diffuse osteopenia.

    Time frame: 6 weeks, 3 months, 6 months, 12 months and 24 months postop

  4. Operative duration

    Time between skin incision to skin closure

    Time frame: Immediately after skin closure

  5. Pain as measured by the Numeric Pain Rating Scale (NPRS)

    The outcome on the Numeric Pain Rating Scale at the time points listed below. The scale ranges from 0 to 10, with a lower score representing less pain and thus a better outcome.

    Time frame: 6 weeks, 3 months, 6 months, 12 months and 24 months postop

  6. Functional outcome ASES

    Functional outcome as measured by the American Shoulder and Elbow Surgeons (ASES) shoulder score. The score values range from 0 to 100, with a lower score representing greater pain and disability.

    Time frame: 6 weeks, 3 months, 6 months, 12 months and 24 months postop

  7. Functional outcome DASH

    Functional outcome as measure by the Disabilities of the Arm, Shoulder and Hand (DASH) score. The score ranges from 0 to 100, with a lower score representing complete, unrestricted functioning of the upper extremities.

    Time frame: 6 weeks, 3 months, 6 months, 12 months and 24 months postop

  8. Hardware related symptoms

    As measured by the Clavicle Hardware Irritation Patient Questionnaires (CHIP-Q). This is a qualitative questionnaire.

    Time frame: 3 months, 6 months, 12 months and 24 months postop

  9. Numbers of patients screened and eligible for the study within the recruitment period

    We are interested in understanding how many people are eligible for the study.

    Time frame: Enrollment

  10. Numbers of patients who agree to participate

    We are interested in understanding how many people agree to participate in the study.

    Time frame: Through study completion, an average 2 years

  11. Number of patients who have missed data points or time points

    We are interested in understanding how many people have missed data points or time points in the study.

    Time frame: Through study completion, an average 2 years

07

Study locations

1 of 1 sites recruiting
  • Sunnybrook Health Sciences Centre
    Toronto, Ontario M4N 3M5, Canada
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 24, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05231343
Lead sponsor
Sunnybrook Health Sciences Centre
Collaborators
Canadian Orthopaedic Trauma Society
Responsible party
Dr. Ujash Sheth (Orthopaedic Surgeon, Sunnybrook Health Sciences Centre) — Principal investigator
First posted
Feb 9, 2022
Start date
Apr 4, 2022
Primary completion
Jan 2027 (estimated)
Completion
Jan 2028 (estimated)
Last update
May 24, 2023

Study contacts

Sara Aman, BSc
Contact
orthores@sunnybrook.ca
416-480-4285
Katrine Milner, BSc
Contact
katrine.milner@sunnybrook.ca
Ujash Sheth, MD MSc FRCSC
principal investigator · Sunnybrook Health Sciences Centre

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion